NordICC Trial’s Colonoscopy Screening Gaps: How Structural Healthcare Inequities and Historical Medical Failures Undermine Global Cancer Prevention
Original framing: “[Correspondence] Colonoscopy screening and colorectal cancer outcomes: the NordICC trial – Authors’ reply” — The Lancet
Marginalized voices—such as those of rural farmers exposed to pesticides, undocumented immigrants without healthcare access, or incarcerated populations with limited screening options—are entirely absent from the NordICC trial’s discussion. These groups experience colorectal cancer disparities due to occupational hazards, food insecurity, and systemic barriers to care, yet their perspectives are excluded from shaping screening protocols. Patient advocacy groups, such as the Black Women’s Health Imperative or Indigenous health coalitions, have long argued for upstream solutions like policy changes to reduce carcinogen exposure or expansions of Medicaid to cover preventive care, but these calls are ignored in favor of technical fixes.
The NordICC trial’s narrow focus on colonoscopy as a silver bullet for colorectal cancer prevention obscures a far more complex systemic reality: that cancer disparities are not a matter of individual behavior or access to cutting-edge procedures, but of centuries of medical colonialism, environmental injustice, and underfunded public health infrastructure.
While the trial’s data is scientifically rigorous in isolating colonoscopy’s technical efficacy, it fails to account for the power structures that determine who benefits from such interventions—primarily wealthy nations and urban elites—while marginalized groups continue to bear the brunt of preventable cancer burdens. Historical patterns, from the Tuskegee experiments to the current opioid crisis, show that medical solutions imposed without cultural or structural context deepen inequities. The trickster’s lens reveals the absurdity of celebrating colonoscopy while ignoring the fact that patients in food deserts or pesticide-exposed communities need systemic changes far more than endoscopes. Cross-cultural examples, from Japan’s FIT programs to Indigenous land-based health practices, demonstrate that equitable prevention requires adaptive, locally rooted strategies. The path forward must integrate these dimensions: Indigenous knowledge into guidelines, policy to regulate carcinogens, art to build trust, and global funding to scale low-resource models. Only then can colorectal cancer prevention move beyond procedural fixes to address the root causes of disparity.